Polydex Pharmaceuticals Issues Third Quarter Financial Results
Company remains profitable with strong balance sheet and cash positionTORONTO, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink...
Year: 2020
Novan Exceeds 60% Enrollment in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
– Completion of patient enrollment targeted for Q1 2021 with readout of topline results targeted for Q2 2021 – –...
Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leukemia (AML)
CRANBURY, N.J., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing...
Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement
Merger brings lead compound CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant...
Assertio Announces Restructuring Plan and Leadership Changes
Expected to Reduce Costs by $45 Million AnnuallyLAKE FOREST, Ill., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio”...
REPEAT – Pure Extracts Applauds Health Canada SAP for Psilocybin-Assisted Psychotherapy Inclusion
--Special Access Programme Review Considered a Milestone Event Toward Mainstream Acceptance VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) --...
TOMI Continues the Deployment of SteraBot™ Disinfection Robot at Multiple Healthcare and Educational Facilities
FREDERICK, Md., Dec. 15, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”, “the Company”) (NASDAQ: TOMZ), a global company...
Zomedica to Remain Domiciled in Canada
Progress Continuing Toward Commercialization of TRUFORMA™ANN ARBOR, Mich., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or...
Eve & Co Announces Licensing Agreement with Dr. Kerklaan Therapeutics
Well-known CBD skincare brand distributed in the USA, UK and Europe bolsters Eve & Co’s product portfolioSTRATHROY, Ontario, Dec. 15,...
Grey Cloak Tech Inc. Subsidiary BergaMet NA™ Announces Sales Agreement with Major Key Account, Xymogen®
Xymogen® is a leading manufacturer and distributor of clinical grade nutraceuticals and ranked among the nation’s fastest-growing privately held companiesLAS...
Brain Scientific, Creator of Next Gen Neurology Technologies, Announces Regulation A+ Offering
Widening Its Investor Network Will Allow Brain Scientific to Continue Its Work in Creating Advanced Technology Devices and Software for...
Auris Medical Provides Business Update
Net cash inflow of $13.4 million from recent registered direct offering and warrant exercises AM-301 program progressing towards clinical and regulatory...
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. rNAPc2 development focused on unmet need for treatments in...
Zealand Pharma announces data from the first phase 3-trial with dasiglucagon in Congenital Hyperinsulinism (CHI)
Company announcement – No. 62 / 2020 Dasiglucagon on top of standard of care (SOC) did not significantly reduce the...
Way2Grow (W2G) Biopharma Company Enters Cannabis Productivity and Announces Plans to Seek Health Canada Approval for Magic Mushroom (Psilocybin and Psilocin) Dealer and Research Licencing
OSOYOOS, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately held...
Algernon Pharmaceuticals Announces Positive Trending Interim Data for its Phase 2b/3 Ifenprodil COVID Study
VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz As Executive Vice President of Technical Operations
Former head of commercial API manufacturing at Gilead Sciences will lead technical operations for development of Cidara’s antifungal and antiviral...
Idera Pharmaceuticals Announces $5.0 Million in Further Proceeds from Private Placement of up to $20.7 Million
EXTON, Pa., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced the closing of a second...
Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment
Thursday, December 17th @ 12:00pmET New York, NY, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading...
Immutep Operational Update
Efti clinical trial status updatesExcellent financial position following recent US$7.7 million warrant exercise, with cash runway extended beyond end of...